Osimertinib

Osimertinib After Lung Cancer Surgery: What Patients Ask About Adjuvant Therapy

Having lung cancer surgery can bring enormous relief—and then a new set of questions. If your oncologist has recommended osimertinib after surgery, you may wonder: If the tumour was removed, why do I need more treatment? Does this mean the cancer is still there? How much will it help? Osimertinib is a targeted anti-cancer medicine. […]

Osimertinib After Lung Cancer Surgery: What Patients Ask About Adjuvant Therapy Read More »

Lung Cancer Medicine Access for International Patients: A Complete Guide

Introduction Receiving a lung cancer diagnosis can be overwhelming. For many patients, the next challenge is not choosing a treatment—it’s finding access to the medicine their oncologist has prescribed. In many parts of the world, targeted lung cancer medicines may not yet be available, may be temporarily out of stock, or may be priced beyond

Lung Cancer Medicine Access for International Patients: A Complete Guide Read More »

Osimertinib NSCLC First-Line Treatment: A Complete Patient Guide

Introduction The treatment landscape for non-small cell lung cancer (NSCLC) has changed dramatically over the past decade. For patients whose tumors carry specific EGFR (Epidermal Growth Factor Receptor) mutations, targeted therapies have significantly improved survival and quality of life compared with traditional chemotherapy. Among these targeted treatments, Osimertinib has become the preferred first-line treatment for

Osimertinib NSCLC First-Line Treatment: A Complete Patient Guide Read More »

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide

Introduction For many patients with EGFR-mutated non-small cell lung cancer (NSCLC), targeted therapy has transformed treatment outcomes. Earlier EGFR inhibitors helped many patients control their cancer for months or even years. However, over time, some cancers develop resistance, making these medicines less effective. One of the most common resistance mechanisms is the EGFR T790M mutation.

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide Read More »

The Hidden Cost of Cancer: More Than Just Medical Bills

Introduction When someone is diagnosed with cancer, the first concern is naturally their health. Questions about treatment, recovery, and survival quickly take center stage. But for millions of patients and families worldwide, another battle begins almost immediately—the hidden financial and emotional cost of living with cancer. Cancer is not only a medical condition. It is

The Hidden Cost of Cancer: More Than Just Medical Bills Read More »

osimertinib dosage

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide)

One of the most common questions patients and caregivers ask after a new prescription is simple: why this dose, and not the other one? Osimertinib is available in two strengths — 40 mg and 80 mg — and the choice between them depends on several factors specific to each patient. This guide explains how Osimertinib

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide) Read More »

How to Access Osimertinib in India Legally — A Step-by-Step Guide

One of the most common questions we receive at CBMeds is: “Is it legal to get Osimertinib from India?” The answer is yes. This guide explains exactly how it works, what documents you need, and what the process looks like from first inquiry to doorstep delivery. Whether you are a patient, a family member, or

How to Access Osimertinib in India Legally — A Step-by-Step Guide Read More »

EGFR Positive Lung Cancer — A Complete Guide for Patients and Families

Being told you have EGFR positive lung cancer can feel overwhelming. But here is something important to know from the start: an EGFR mutation in lung cancer is not just a diagnosis — it is a specific piece of information that opens the door to some of the most effective targeted treatments available in oncology

EGFR Positive Lung Cancer — A Complete Guide for Patients and Families Read More »